Clinical Trial

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This trial studies how well proton beam radiation therapy compared with intensity modulated photon radiotherapy works in treating patients with stage I-IVA esophageal cancer. Proton beam radiation therapy uses a beam of protons (rather than x-rays) to send radiation inside the body to the tumor without damaging much of the healthy tissue around it. Intensity modulated photon radiotherapy uses high-energy x-rays to deliver radiation directly to the tumor without damaging much of the healthy tissue around it. It is not yet known whether proton beam therapy or intensity modulated photon radiotherapy will work better in treating patients with esophageal cancer.
Protocol Amendment History 31 amendments
This ClinicalTrials.gov record has been amended 31 times since 2019-01-09; most recent amendment 2026-06-22.
Status change: Not Yet Recruiting → Recruiting 2019-06-18
Trial Details
NCT Number NCT03801876
Lead Sponsor NRG Oncology
Collaborators: National Cancer Institute (NCI)
Conditions Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 +5 more
Enrollment 300 participants
Start Date 2019-06-26
Primary Completion 2026-12-21 (estimated)
Study Completion 2031-12-21 (estimated)
Updated on ClinicalTrials.gov 2026-06-25